Programmed Death Ligand 2 in Cancer-Induced Immune Suppression
Open Access
- 29 April 2012
- journal article
- review article
- Published by Hindawi Limited in Journal of Immunology Research
- Vol. 2012, 1-8
- https://doi.org/10.1155/2012/656340
Abstract
Inhibitory molecules of the B7/CD28 family play a key role in the induction of immune tolerance in the tumor microenvironment. The programmed death-1 receptor (PD-1), with its ligands PD-L1 and PD-L2, constitutes an important member of these inhibitory pathways. The relevance of the PD-1/PD-L1 pathway in cancer has been extensively studied and therapeutic approaches targeting PD-1 and PD-L1 have been developed and are undergoing human clinical testing. However, PD-L2 has not received as much attention and its role in modulating tumor immunity is less clear. Here, we review the literature on the immunobiology of PD-L2, particularly on its possible roles in cancer-induced immune suppression and we discuss the results of recent studies targeting PD-L2 in cancer.Keywords
This publication has 75 references indexed in Scilit:
- Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunityCurrent Opinion in Immunology, 2012
- An essential role for TH2-type responses in limiting acute tissue damage during experimental helminth infectionNature Medicine, 2012
- Activation of STAT6 by STING Is Critical for Antiviral Innate ImmunityCell, 2011
- PD-L1 and PD-L2 modulate airway inflammation and iNKT-cell-dependent airway hyperreactivity in opposing directionsMucosal Immunology, 2009
- PD-1 ligand expression by human colonic myofibroblasts/fibroblasts regulates CD4+ T-cell activityGastroenterology, 2008
- Programmed Death-1 Ligand 1 Interacts Specifically with the B7-1 Costimulatory Molecule to Inhibit T Cell ResponsesImmunity, 2007
- Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+T lymphocytes are prognostic factors of human ovarian cancerProceedings of the National Academy of Sciences of the United States of America, 2007
- Regulation of T cell activation and tolerance by PDL2Proceedings of the National Academy of Sciences of the United States of America, 2006
- T-cell tolerance or function is determined by combinatorial costimulatory signalsThe EMBO Journal, 2006
- No evidence for dualism in function and receptors: PD‐L2/B7‐DC is an inhibitory regulator of human T cell activationEuropean Journal of Immunology, 2006